Outcomes | Hazard Ratio | 3-year Probability |
---|---|---|
Non-relapse mortality | ||
Matched URD HCT | 1.00 | 25% (95% CI 21–29) |
Haploidentical HCT | 1.02 (95% CI 0.70–1.48) p = 0.92 | 22% (95% CI 15–29) |
Relapse | ||
Matched URD HCT | 1.00 | 40% (95% CI 35–44) |
Haploidentical HCT | 0.99 (95% CI 0.72–1.37) p = 0.95 | 41% (95% CI 33–49) |
Survival | ||
Matched URD HCT | 1.00 | 47% (95% CI 42–51) |
Haploidentical HCT | 1.27 (95% CI 1.01–1.59) p = 0.04 | 43% (95% CI 34–51) |